Post-Approval Observational Cohort Study to Evaluate the Safety of the COMIRNATY 2023-2024 Formula in the United States

03/01/2024
26/03/2026
EU PAS number:
EUPAS108135
Study
Ongoing
Documents
Study protocol
Initial protocol
English (682.6 KB - PDF) View document
Updated protocol
English (716.96 KB - PDF) View document
English (1.02 MB - PDF) View document
Study results
Study report
Other information